Delivery Order SPE2DB24D2010-SPE2DB24FZRY1
- Not listed
- This federal contract award, valued at $2,342.24, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order to supply the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,886.45 delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, and has an ultimate completion date of April 4, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $13,102.08 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of October 27, 2022 and was made on October 26, 2022. This Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,922.72, is for the delivery of 4,564,361,217 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This contract has a completion date of April 23, 2024 and is a firm fixed-price arrangement. The IDC held by Cencora, Inc. with the DLA is...
- This federal contract award, valued at $2,938.11, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of December 1, 2023. The contract is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $91,846.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order that covers the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $1,302.06 for the supply of NURTEC ODT 75 MG TABLET 8S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an Ultimate Completion Date of December 17, 2021. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $24,902.60 for the supply of NURTEC ODT 75 MG TABLET 8S medical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,736.86 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $8,936.50 delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through January 24, 2024. The parent IDC held by Cencora, Inc. is valued at up to $999,999,999.00 and runs through December 31, 2025. This...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZRY1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,078.20 fixed-price delivery order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no set-aside designation, indicating this was a full and open competition. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs worldwide. Cencora, Inc. also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.1k | 2/22/24 |